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Experimental autoimmune encephalomyelitis (EAE) is an inlammatory demyelinating disease of the central 
nervous system (CNS). It is the most commonly used animal model for the study of human multiple sclerosis 
(MS), a condition which afects approximately 2.5 million people worldwide and is one of the leading causes of 
neurological disability in young adults. EAE is thought to be mediated predominantly by efector h1 and h17 
cells activated by antigen presenting cells, which leads to demyelinating CNS inlammation.
Mitogen-activated protein kinases (MAPKs) control a vast array of important physiopathological processes 
including various immune responses to stimuli/stress/damage in multicellular organisms. MAPK phosphatases 
(MKPs) are a group of dual speciic phosphatases (DUSPs) which deactivate the MAPKs (i.e. ERK, JNK, p38) via 
dephosphorylation of phosphotyrosine and phosphothreonine residues, and thus play a key role in inlammation 
mediated diseases. Indeed various MKPs including MKP-1, MKP-5, MKP-7, MKP-x (DUSP22) and DUSP5 have 
been shown to be important in regulating immune responses1–6. For example, MKP-1 negatively regulates the 
production of inlammatory cytokines TNF-α , IL-6 and IL-1β , and the anti-inlammatory IL-107–9, as well as 
chemokines and other inlammatory mediators10–13. Increased immune responses have also been observed in 
MKP-1 deicient mice ater LPS administration compared with wild type controls14. During CNS inlammation, 
EAE severity is ameliorated in the absence of MKP-115 and MKP-516 while MKP-x deicient mice are more sus-
ceptible to EAE17.
MKP-2 is a dual-speciicity phosphatase (DUSP-4) localised within the nucleus and is expressed in a wide 
range of cells and tissues including the CNS18,19. It regulates ERK, JNK or p38 pathways depending on cell type. 
MKP-2 is well documented to be an important immune response modulator in a number of diseases. In acute 
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lung injury (ALI), MKP-2−/− mice had reduced TNF-α and MIP-1α production and neutrophil lung iniltra-
tion20, while a signiicantly reduced mortality was also exhibited in the gene deicient mice in sepsis which was 
associated with decreased serum levels of TNF-α , IL-1β , IL-6 and IL-1021. We recently reported that MKP-2 dele-
tion led to a greater susceptibility to Leishmania Mexicana22 and Toxoplasma gondii23 infection in mice, but with 
diferent underlying immune mechanisms.
he role of MKP-2 in CNS inlammatory diseases such as MS is currently unknown, this study investigated the 
function of MKP-2 during the development of CNS inlammation in EAE using MKP-2 deicient mice. Our data 
show that the mRNA expression levels of MKP-2 were signiicantly upregulated in the CNS and lymphoid organ 
tissues of EAE mice compared to naïve control animals. When EAE was induced in MKP-2+/+ and MKP-2−/− mice, 
we observed reduced clinical scores of EAE in the gene deicient mice, which was associated with reduced inlam-
mation and immune cell iniltration in the spinal cord tissues. Analysis of immune responses indicates that the fre-
quency of CD4+ and CD8+ T cells, and CD11c+ MHC-II+ dendritic cells (DCs) in the peripheral lymphoid organs 
was decreased, together with reduced production of antigen speciic pro-inlammatory cytokines by the lym-
phoid cells. Finally our experiments using bone marrow derived DCs (BMDCs) suggest that DCs from MKP-2−/− 
KO mice had signiicantly reduced expression of MHC-II and costimulatory molecules and impaired capabil-
ity in T cell activation, in addition to the intrinsic defect of MKP-2 deicient T cells in activation and cytokine 
production.

Ǧ ?Ǥ To understand the role of MKP-2 
in EAE, we irst examined whether there is a correlation between EAE disease severity and the expression levels 
of MKP-2. C57BL/6 mice were immunised, spinal cord, spleen and dLN tissues of EAE mice were collected at the 
stages of disease onset (day 9–11, when mice develop tail paralysis), peak (day 15–17 when mice exhibit hind limb 
paralysis) and resolution (day 26–28 when mice had steady reduced clinical scores ater the peak). he expression 
of MKP-2 mRNA was measured by qPCR and our data show that there was a signiicant 1.9 ± 0.2-fold increase 
in the mRNA of MKP-2 in EAE spinal cord tissues at disease onset, and the levels were further increased to 
3.8 ± 0.8-fold at EAE peak, when compared with spinal cord tissues of naïve controls (Fig. 1A). At the resolution 
stage, when mice display milder clinical symptoms of EAE, MKP-2 mRNA levels in the spinal cord were compa-
rable between EAE and naïve counterparts.
To study whether MKP-2 is also a potential mediator of the peripheral immune responses in CNS inlam-
matory disease, we next determined the expression levels of MKP-2 in the spleen and dLN tissues during EAE 
development. Our data show that there was a signiicant increase of MKP-2 mRNA expression in both spleen and 
dLN tissues in EAE mice compared to naïve animals at peak and resolution stages (Fig. 1B,C), with MKP-2 also 
signiicantly upregulated in dLN tissues at EAE onset. We further assessed antigen speciic MKP-2 expression 
in EAE spleen and dLN cells by ex vivo MOG peptide stimulation. Single cell suspensions were cultured with or 
without MOG35–55 for up to 4 hours before cells were collected and MKP-2 expression analysed by qPCR. Our 
results show that in spleen cells (Fig. 1D), MKP-2 mRNA expression was signiicantly increased by 5.8 ± 1.1-fold 
relative to unstimulated cells ater 1 hour (Fig. 1D), and levels began to decrease ater this but remained signii-
cantly upregulated. he expression levels were also signiicantly increased in MOG35-55 cultured LN cells at 2 and 
4 hours, with the expression at 3.4 ± 0.6-fold and 4.7 ± 1.3-fold higher respectively (Fig. 1E).
Ǧ ?ƤǤ In order to determine how prominent MKP-2 is in 
EAE pathogenesis, we investigated the efect of mkp-2 gene disruption on disease development and progression. 
EAE was induced in MKP-2−/− mice and MKP-2+/+ littermates. Our data show that there was no diference in 
the overall incidence of disease between the two groups as all mice in both groups developed EAE (Fig. 2A). 
However, while MKP-2+/+ mice started to show EAE signs at day 9 and all mice developed EAE at day 14 ater 
immunisation, MKP-2−/− mice had a delayed disease onset showing loss of tail tone at day 11 and not reaching 
100% incidence until day 18 (Fig. 2A). Furthermore, MKP-2−/− mice developed signiicantly less severe clinical 
symptoms of EAE compared to MKP-2+/+ mice throughout the time course (Fig. 2B), with the average EAE score 
of the MKP-2+/+ group reaching a peak of 3 compared to just 2.1 in MKP-2−/− mice.
To investigate the extent of inlammation and cellular iniltration in the CNS, spinal cord tissues from peak 
EAE mice were harvested and H&E staining was carried out. Conirming the clinical data that less severe EAE 
was observed in MKP2−/− mice, histological examination showed reduced lesions and reduced number of inil-
trating cells particularly in the white matter of MKP-2−/− spinal cord sections compared to MKP-2+/+ tissue 
(Fig. 2C). Following that, we performed immunohistochemical staining of speciic immune cell surface markers 
to identify the CNS iniltrating cell phenotype. Data in Fig. 2C demonstrate that there was a dramatic decrease 
of CD45+ iniltrating immune cells in the lesions of MKP-2−/− mice spinal cords compared with MKP-2+/+ tis-
sues, and that the majority of these iniltrating cells were likely to be CD4+ T cells and CD11b+ macrophages, 
together with some CD8+ and CD11c+ cells. hese data thus suggest that MKP-2 deiciency leads to reduced CNS 
inlammation.
Ǧ ?ƤƤƤǤ To under-
stand the mechanistic basis of reduced EAE observed in MKP-2−/− mice, we irst investigated the cytokine pro-
duction proile of the immune cells within secondary lymphoid tissues during EAE progression. Spleen and dLNs 
cells were collected from MOG peptide immunized MKP-2+/+ and MKP-2−/− mice at EAE peak stage. Single 
cell suspensions were collected and cultured for 72 hours with or without MOG35-55 and supernatants collected 
for analysis of various cytokines by ELISA. While very low levels of cytokine and chemokine were detected in 
the supernatants of cultures without MOG35-55 and with no diference between the two groups (data not shown), 
our results show that there was a MOG-speciic response induced in both groups of lymphoid cells. he spleen 
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and dLN cells of MKP-2−/− mice produced signiicantly less antigen speciic IFN-γ , IL-17, IL-6 and IL-22 in the 
culture compared to MKP-2+/+ (Fig. 3), and the diference was more signiicant in spleen tissues. In addition, 
production of the chemokine CCL-2 was also signiicantly reduced in MKP-2−/− spleen cells (Fig. 3).
Ǧ ?ƤǤ Next we analysed the immune 
cell phenotype in the spleen and dLN tissues of MKP-2+/+ and MKP-2−/− naïve and EAE mice (Fig. 4). Single 
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Figure 1. MKP-2 mRNA expression is increased in tissues of EAE mice. (A) Spinal cord, (B) spleen and  
(C) dLN tissues were harvested from naïve C57BL/6 mice or at EAE onset, peak and resolution stages of 
MOG35-55 immunised mice. RNA was isolated and reverse transcribed to allow analysis of MKP-2 mRNA 
expression by quantitative PCR. (D) Spleen and (E) dLN tissues were harvested from EAE peak mice and 
single cell suspensions prepared and cultured with or without MOG35-55 for the times indicated. Cells were 
then harvested for analysis of MKP-2 mRNA expression by quantitative PCR. Results show changes in MKP-2 
mRNA expression relative to naïve tissue or unstimulated cells using the 2-∆ ∆ CT method. (A–C) Each symbol 
represents an individual mouse and bar indicates the average value of relative MKP-2 expression in each group. 
(D–E) Graphs show data from  two independent experiments, n = 8. *P < 0.05.
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cell suspensions were collected and stained for various cell surface markers and analysed by low cytometry. 
Expression of CD4 and CD8 T cells were irst examined (Fig. 4A and B). Our data show that no diference was 
observed in the frequency of CD4 and CD8 positive cells in the lymphoid tissues between naïve MKP-2+/+ 
and MKP-2−/− mice. However, in EAE mice, the frequency of CD4+ T cells and CD8+ T cells was signiicantly 
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Figure 2. MKP-2−/− mice develop less severe EAE then MKP-2+/+ counterparts. MKP-2+/+ and MKP-2−/−  
mice were inmmunised as described in Materials and Methods. (A) EAE incidence in MKP-2+/+ and  
MKP-2−/− mice, n = 24 in each group. (B) Clinical score of EAE development in MKP-2+/+ and MKP-2−/−  
mice. Data show mean ± SEM of 24 mice per group from at least 4 independent experiments. *P < 0.05; 
**P < 0.01, ***P < 0.001. (C) H&E, CD45, CD4, CD8, CD11b and CD11c staining of spinal cords 17 days post 
immunisation. Images are representative of at least 12 mice per group from three independent experiments, 
scale bars = 100 µ m.
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decreased in the MKP-2−/− group compared with MKP-2+/+ littermates at day 17 ater immunisation with peak 
EAE clinical severity.
Further analysis of myeloid cell populations indicated that there was no diference of CD11c and CD11b 
expression in the spleen or dLNs tissues between the WT and KO mice in naïve or EAE immunised mice (data 
not shown). However there was a signiicant reduction in the frequency of MHC-II+ cells in the spleen (Fig. 4C) 
and dLNs (Fig. 4D) tissues of MKP-2−/− mice when compared to that of the MKP-2+/+ littermates at the peak of 
EAE, whereas no such diference was observed between naïve MKP-2−/− and MKP-2+/+ mice (data not shown). 
As DCs are professional antigen presenting cells and activated DCs express high levels of MHC-II, we studied the 
frequency of CD11c+ MHC-II+ cells in spleen and LNs. We observed a signiicant reduction in the frequency of 
CD11c and MHC-II double positive cells in the lymphoid organs of MKP-2−/− EAE mice compared with MKP-2+/+ 
controls (Fig. 4C and D). In addition, the percentage of CD11c+ CD40+ cells was also signiicantly reduced in the 
MKP-2−/− mice (Fig. 4C and D). he reduced EAE severity in MKP-2 deicient mice thus was likely associated 
with reduced frequency of lymphocyte numbers, as well as MHC-II+ and CD40+ DCs in the spleen and dLNs.
Ǧ ? ?+Ǥ In order to determine whether the altered immune cell 
cytokine production and reduced T cell frequency in EAE development may be due to an intrinsic change in T cell 
function as a result of MKP-2 deletion, CD4+ T cells were puriied from spleens of naïve MKP-2+/+ and MKP-2−/− 
mice and activated with plate-bound anti-CD3 and anti-CD28. T cell proliferation was measured by MTT assay 
Figure 3. MKP-2−/− mice display a reduced immune response during EAE development compared 
to MKP-2+/+ mice. Spleens and dLNs were harvested at EAE peak and disrupted to form individual cell 
suspensions. Cells were stimulated with or without MOG35-55 for 72 hours and supernatants collected for 
analysis of cytokine expression by ELISA. Graphs show mean ± SEM of three independent experiments, n = 12 
per group *P < 0.05; **P < 0.01, ***P < 0.001.
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ater 48 hours and 96 hours of culture, and cytokine levels in the supernatants ater 72 hours culture were meas-
ured by ELISA. Our data show that MKP-2−/− T cells display reduced proliferation following the polyclonal 
activation compared to MKP-2+/+ cells (Fig. 5A). In addition, CD4+ T cells from MKP-2−/− mice produced less 
IL-2 and IL-17 whereas IFN-γ production was unchanged between the two groups (Fig. 5B). hese data suggests 
that MKP-2 is involved in regulation of CD4+ T cell proliferation but may play a more important role in speciic 
CD4+ T cell subsets such as h17 cells.
Ǧ ?Ǥ To further investigate whether the phenotypically 
altered DCs may also contribute to the decreased proinlammatory response, and thus attenuated EAE severity, in 
MKP-2−/− mice, we next examined the phenotype and function of DCs derived from the bone marrow of MKP-
2−/− and MKP-2+/+ mice. BMDCs were generated in culture with GM-CSF and cells were then stimulated with 
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Figure 4. Altered phenotypte of immune cells in naïve and EAE MKP-2+/+ and MKP-2−/− mice lymphoid 
organs. (A and B) Cells from naïve and EAE spleen and dLNs were stained for CD4 and CD8 and analysed by 
low cytometry. (A) FACS plots of dLN tissue cells are representative of at least 10 mice per EAE group  
(MKP-2+/+ and MKP-2−/− mice) from three independent experiments. (B) Bar graphs show combined data 
from three independent experiments with n = 10 in each group, N refers to naïve, and Spl refers to spleen in 
the x-axis labelling, bars represent mean ± SEM. (C and D) Expression of MHC-II, CD11c and CD40 by MKP-
2+/+ and MKP-2−/− immune cells in EAE spleen (C) and dLNs (D). Spleen and dLNs were harvested at EAE 
peak and disrupted to form individual cell suspensions. Cells were then stained and analysed for expression of 
MHC-II, or expression of both CD11c and MHC-II molecules, or both CD11c and CD40 by low cytometry. 
Graphs show combined data from three independent experiments, each symbol represents an individual mouse 
and bar indicates the average value of expression in each group. *P < 0.05; **P < 0.01.
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various TLR ligands: 100 ng/ml LPS, 1 µ M CpG or 20 µ g/ml Poly(I:C) for 24 hours before being analysed for the 
expression of CD11c, MHC-II, CD80, CD86 and CD40 by low cytometry (Fig. 6A–E). Our data shows that about 
54% of MKP-2−/− CD11c+ BMDCs cultured in media alone were MHC-II+, signiicantly less than MKP-2+/+ 
cells with 62% (Fig. 6B). Following LPS stimulation, the proportion of MHC-II+ CD11c+ cells from MKP-2+/+ 
mice was 71% with a signiicant increase of 9%. In contrast, activated MKP-2−/− BMDCs displayed only a small 
3% increase in MHC-II expression (Fig. 6B). herefore our data show that MKP-2−/− BMDCs express reduced 
levels of MHC-II relative to their MKP-2+/+ counterparts and also are less capable of upregulating MHC-II in 
response to immune challenge such as TLR4 ligands. Similarly, expression of the co-stimulatory molecules CD40 
(Fig. 6C), CD80 (Fig. 6D) and CD86 (Fig. 6E), were also signiicantly lower in MKP-2−/− mice derived BMDCs 
compared to the cells of MKP-2+/+ mice following LPS stimulation, with CD80 and CD86 levels reduced on 
unstimulated cells similar to MHC-II. It is worth noting that CD40 and CD80 expression was also reduced in 
MKP-2−/− BMDCs in response to TLR9 ligand CpG activation, but not Poly(I:C), a TLR3 agonist (Fig. 6), sug-
gesting MKP-2 afects TLR4 and TLR9 pathways but not TLR3 in BMDCs.
To further test whether the reduced levels of MHC-II and costimulatory molecules had any functional impact, 
the antigen presentation/T cell activation capability of the BMDCs was examined. BMDCs derived from naïve 
MKP-2+/+ and MKP-2−/− mice were pulsed with or without MOG35-55 peptide, cells were then washed thoroughly 
and cocultured with CD4+ T cells isolated from wild type peak EAE mice followed by analysis of T cell prolif-
eration and cytokine production. As expected, T cells co-cultured with MOG35-55 pulsed BMDCs (+ MOG) had 
signiicantly increased levels of proliferation compared with BMDCs without MOG (Medium) stimulation before 
co-culture (Fig. 6F). However those T cells co-cultured with MOG peptide pulsed BMDCs of MKP-2−/− mice had 
reduced proliferation compared to cells cultured with MKP-2+/+ BMDCs (Fig. 6F). Similarly, while co-culture 
of T cells with medium pulsed BMDCs had undetectable levels of cytokine production (data not shown), T cells 
co-cultured with MOG peptide pulsed BMDCs produced high levels of IL-17 and IFN-γ , and the levels were sig-
niicantly reduced in the co-culture supernatants of MKP-2−/− mice BMDCs compared with DCs from MKP-2+/+ 
mice (Fig. 6G).
Ǧ ?Ǥ he role of MKP-2 in infection has 
been closely linked with its efect on macrophage cell activation including cytokine release and NO produc-
tion22,24. We did not observe any diference in the frequency of CD11b+ cells in the spleen and dLNs tissues 
between MKP-2 WT and KO littermates in naïve (data not shown) and EAE conditions (Fig. 7A). When we 
analysed the NO formation in the serum samples of MKP-2+/+ and MKP-2−/− EAE mice using a standard Griess 
reagent system, our results show that nitrite levels were signiicantly increased in EAE mice compared to naïve 
controls as expected (data now shown). However to our surprise there was no diference in NO levels between 
the serum samples of MKP-2+/+ and MKP-2−/− at EAE peak stage, only at the resolution stage we observed a 
signiicant reduction of nitrite, decreasing from 161.8 ± 21.9 µ M in the MKP-2+/+ mice to 80.1 ± 33.8 µ M in the 
MKP-2 deicient mice (Fig. 7B). We also examined NO production by BMMs generated from MKP-2+/+ and 
MKP-2−/− mice in vitro. Our results indicate that while unstimulated MKP-2+/+ and MKP-2−/− BMMs produced 
low levels of nitrite with no diference between the two groups (Fig. 7C), nitrite concentrations were increased 
upon LPS stimulation, and the level was consistently signiicantly reduced in MKP-2−/− BMMs compared to 
MKP-2+/+ counterparts (Fig. 7C), conirming the importance of MKP-2 in macrophage activation and function. 
Interestingly similar to BMDCs, MKP-2 deletion afected macrophage activation in response to both LPS and 
CpG, but not Poly (I:C), as the frequency of NOS2 + cells were signiicantly increased in the MKP-2+/+ BMMs 
ater LPS and CpG stimulation (Fig. 7D).

he function of MKP-2 in MS disease development is of particular interest as MKP-2 is widely expressed in the 
brain tissues25 in addition to its function in the immune system, and MS is a disease characterised by immune 
Figure 5. CD4+ T cells of non-immunised MKP-2−/− mice have reduced cell proliferation and cytokine 
production. CD4+ T cells were isolated from spleens of MKP-2+/+ and MKP-2−/− mice, and then activated in 
culture with anti-CD3 and anti-CD28 antibodies. (A) Ater 48 and 96 hours, T cell proliferation was measured 
by MTT assay. (B) Cell supernatants were also collected ater 72 hours of culture and then cytokine levels were 
measured by ELISA. Values represent mean± SEM of three independent experiments, *P < 0.05; **p < 0.01.
www.nature.com/scientificreports/
8SCIENTIFIC REPORTSȁ ?ǣ ? ? ? ? ?ȁǣ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?
mediated inlammation in CNS. In this report we have shown that MKP-2 expression is signiicantly enhanced 
in the spinal cord as well as the peripheral spleen and dLNs at the onset and peak of EAE, suggesting MKP-2 
is involved in the initiation and development of EAE possibly through mediating the immune responses in 
the peripheral lymphoid organs as well as within the CNS. Indeed, MKP-2 deicient mice developed attenu-
ated EAE, which was shown with reduced CNS inlammation and decreased number of iniltrating immune 
cells. Peripheral immune organs exhibited a reduced percentage of CD4+ and CD8+ T cells and reduced antigen 
Figure 6. BMDCs of MKP −/− mice exhibit reduced expression of MHC-II and costimulatory molecules. 
BMDCs were generated from the culture of bone marrow from MKP-2+/+ and MKP-2−/− mice. Cells were 
stimulated with or without LPS (100ng/ml), CpG (1 µ M) or Poly(I:C) (20 µ g/ml) for 24 hours and CD11c, 
MHC-II, CD40, CD80 and CD86 expression analysed by low cytometry. FACS plots are representative of three 
independent experiments of BMDCs activated by LPS. (A) Cells were gated for CD11c+ cells irst, and then 
the gated positive cells were analysed for their expression of (B) MHC-II, (C) CD40, (D) CD80 and (E) CD86. 
(B–E) Graphs show combined data from three independent experiments, bars represent mean ± SEM.  
(F and G) BMDCs from MKP-2+/+ and MKP-2−/− mice were pulsed with or without MOG35-55 (100 µ g/ml) 
for 4 hours before incubation with puriied CD4+ T cells isolated from wild type EAE mice spleen and dLN 
tissues. (F) Ater 48 hours cell proliferation was determined by MTT assay. (G) Ater 72 hours of culture, cell 
supernatants were collected for cytokine production analysis using ELISA. Values represent mean ± SEM of two 
independent experiments performed in triplicate. *P < 0.05; **P < 0.01, ***P < 0.001.
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speciic proinlammatory cytokine production, and this was likely due to the impaired function of T cells and 
antigen presenting DCs. his study therefore suggests that MKP-2 plays an important role in the development of 
CNS inlammatory diseases possibly through modulating the function of key antigen presenting cells and T cells.
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Figure 7. MKP-2 is important for NO production by macrophages. (A) Spleen and dLNs were harvested at 
EAE peak and disrupted to form individual cell suspensions and cells stained for CD11b expression. FACS plots 
are representative of at least 9 mice per group from three independent experiments. Graphs show combined 
data from three independent experiments, bars represent mean ± SEM. (B) Whole blood was harvested at EAE 
peak and resolution stages and nitrite concentrations determined by Griess Assay. Graphs show mean ± SEM 
of two independent experiments (n = 7 MKP-2+/+; n = 8 MKP-2−/−). (C) BMMs were generated from the 
bone marrow from MKP-2+/+ and MKP-2−/− mice. Cells were stimulated with or without LPS (100 ng/ml) 
and culture supernatant was collected ater 24 hours and nitrite concentrations determined by Griess Assay. 
Values represent mean ± SEM of three independent experiments. (D) BMMs were stimulated with or without 
LPS (100 ng/ml), CpG (1 µ M) or Poly(I:C) (20 µ g/ml) for 24 hours and NOS2 expression was analysed by 
low cytometry following initial gating on CD11b+ cells. FACS plots are representative of three independent 
experiments of BMMs either unstimulated or activated by LPS. Graphs show combined data from three 
independent experiments, bars represent mean ± SEM. *P < 0.05, **P < 0.01.
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Despite recent efort to understand the roles of MKPs in immune regulation, it is currently not known whether 
MKP-2 plays a role in the development of neuroinlammation in CNS. Our indings of attenuated EAE in the 
MKP-2−/− mice together with signiicantly reduced percentages of CD4+ and CD8+ cells in the spleen and dLNs 
compared to MKP-2+/+ mice indicate that MKP-2 is likely to be essential for CD4+ and CD8+ T cell expansion in 
lymphoid organs during the development of CNS inlammation. Furthermore, CD4+ T cells from naïve MKP-2−/− 
mice were shown to have reduced cell proliferation and impaired IL-17 and IL-2 production in response to CD3/
CD28 activation, suggesting an intrinsic functional alteration of these T cells due to MKP-2 deletion. he data 
agree with our previous reports that MKP-2 deicient mice had a diminished h1 response or a general T cell 
hypo-responsiveness depending on the infected pathogens22,24. Interestingly while we observed an impaired IL-17 
and IL-2 production by T cells from MKP deicient mice, IFN-γ production was comparable to that of MKP-2+/+ 
mice, suggesting that MKP-2 is likely to be involved in the activation of speciic T cells and immune molecules. 
Nevertheless, our study supports the recent indings from other groups1,15,26,27 that MKPs are critical regulators of 
T cell activation and function. For example, MKP-1 was shown to be required for T cell activation and function. 
T cells deicient in MKP-1 had impaired cell activation, proliferation, and function in vitro and the gene deicient 
mice were more resistant to EAE development15. MKP-5 has diferential roles in the regulation of T cell clonal 
expansion and efector T cell cytokine expression, MKP-5 deicient T cells proliferated poorly upon activation 
which resulted in increased resistance to EAE than the wild type controls16. he emerging research evidence thus 
suggests that MKPs play important roles in the regulation of inlammatory responses such as sepsis, infection 
and CNS inlammation2,3,5,21, and they may become potential therapeutic targets for inlammatory diseases such 
as MS.
Associated with the reduced EAE severity and T cell expansion in the MKP-2−/− mice, our data also indicate 
that the levels of antigen speciic IL-6, IL-17, IL-22 and IFN-γ production by ex vivo cultured lymphoid cells 
from both spleen and dLNs were all signiicantly reduced in the MKP-2−/− group compared to MKP-2+/+ con-
trols. herefore a further possible mechanism of action of MKP-2 during EAE pathogenesis and progression is 
via the regulation of cytokine production, including IL-17 and IFN-γ which are secreted by h17 and h1 cells 
respectively. While several previous studies suggest MKPs such as MKP-1 can dynamically regulate both pro- and 
anti-inlammatory cytokine production e.g. IL-6, TNF-α and IL-10 by innate immune cells8–10, two very recent 
reports suggest that some phosphatases are able to directly regulate h17 cell diferentiation and function. MKP-1 
is shown to control IL-17R signalling and tissue inlammation by the p38α -MKP-1 signalling axis in EAE28, while 
DUSP2 regulates h17 diferentiation through controlling the activity of STAT329. Our indings of reduced levels 
of IL-17 by naïve MKP-2−/− mice CD4+ T cells in response to CD3/CD28 activation, together with decreased 
antigen speciic production of IL-17 and IL-22, a cytokine that can also be produced by h17 cells along with 
IL-17, by cultured spleen and dLNs cells of MKP-2−/− mice support a potential role of MKP-2 in regulating h17 
cells, but the underpinning molecular mechanisms remain to be determined.
It is not clear what caused the dramatically reduced inlammatory cell iniltration into the spinal cord in the 
MKP-2 deicient mice, one possible explanation could be the altered chemokine expression by immune cells in 
the absence of MKP-2 which afects cell migration to areas of inlammation. Reduction of neutrophil iniltration 
in the lung of MKP-2−/− mice was closely associated with decreased MIP-1α expression in BAL luids in a mouse 
model of ALI20. Furthermore, other MKPs including MKP-1 have also been shown to control chemokine expres-
sion such as CCL2, CCL3, CXCL1 and CXCL2 in response to LPS administration10,13,30. In our study we observed 
that CCL2 level was signiicantly decreased in MKP-2−/− EAE spleen cells following MOG stimulation. As CCL2 
acts as a chemoattractant for a variety of immune cells, MKP-2 could potentially afect the level of cell migration 
to sites of inlammation, thereby increasing autoimmune pathology.
MKP-2 is shown to exhibit important functions in modulating immune responses, particularly T cells, in EAE 
and various diseases as shown by us and others20–24. However it is not yet known whether and how it regulates 
the key antigen presenting DCs. We observed a signiicantly reduced frequency of CD11c+ MHC-II+ DCs in 
MKP-2 deicient mice spleen and dLNs at peak of EAE disease compared with MKP-2+/+ controls. Similar obser-
vations were also seen in BMDCs, with MKP-2−/− mice cells expressing signiicantly lower levels of MHC-II as 
well as the costimulatory molecules CD40, CD80 and CD86 in response to LPS. While MKP-2 deletion altered 
BMDC activation by LPS and CpG, ligands of TLR4 and TLR9 respectively, it did not afect the signalling via 
TLR3, suggesting MKP-2’s function varies in diferent TLR signalling pathways and this was also conirmed 
in BMM cells. Furthermore, functional tests of BMDCs co-cultured with puriied CD4+ T cells from wild type 
EAE mice indicate the BMDCs of MKP-2−/− mice had impaired capability of activating antigen speciic T cells 
as the co-cultured cells had reduced proliferation and IL-17 and IFN-γ production. Our data therefore suggest an 
important but currently unrecognised role of MKP-2 in directly regulating DC function. In addition to the intrin-
sic defect of CD4+ T cells, MKP-2 deiciency alters DC activation phenotype which results in impaired antigen 
presentation and reduced T cell function and cytokine production, and ultimately decreases clinical symptoms in 
EAE. It is not yet clear how MKP-2 modulates MHC-II expression in DCs. Previous reports suggest MHC-II gene 
expression is regulated by the transcriptional coactivators RFX and CIITA31,32, while the expression of CIITA is 
controlled by ERK and p38 activity through a negative feedback loop33. Indeed MKP-1 deicient macrophages and 
DCs displayed reduced expression of CIITA and MHC-II ater being activated33. herefore it would be interesting 
to know whether the reduced expression of MHC-II in MKP-2−/− DCs is due to altered CIITA expression via 
MAPK dephosphorylation.
Whilst our data here suggest a novel function of MKP-2 in regulating DC function and T cell activation, the 
importance of MKP-2 in macrophage diferentiation and activation has been well documented, with MKP-2 dei-
ciency potentiating LPS-induced production of inlammatory cytokines IL-6, IL-12 and TNF-α by BMMs, as well 
as modulating iNOS and Arginase-1 production22,23. In our study we observed similar diferences in BMM phe-
notype and cytokine production proile between the MKP-2+/+ and MKP-2−/− BMMs ater LPS stimulation (data 
not shown), conirming these previous reports. In addition, our data revealed that BMMs from MKP-2−/− mice 
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had reduced levels of NO production ater LPS activation, and this was conirmed in EAE mice at day 28 ater 
immunisation. While the positive regulation of MKP-2 on NO production would enhance disease pathogenesis 
as NO is known to contribute to the inlammatory response and demyelination of MS/EAE, the diference of 
NO levels only shown on day 28 but not day 17 ater immunisation may suggest a dominant role of MKP-2 in 
modulating the adaptive immune response in the development of EAE through its efect on antigen presenting 
DC function, rather than macrophages. We also observed no diference in the production of reactive oxygen spe-
cies by PMA activated neutrophils puriied from MKP-2+/+ and MKP-2−/− mice bone marrow tissues (data not 
shown), further conirming a speciic role of MKP-2 in myeloid DC activation and function.
While our study focused on the role of MKP-2 in the immune response during EAE development, it is worth 
noting that various MKPs are important in CNS function and diseases. MKP-3 regulates the activities of oli-
godendrocytes, microglia and neurons34,35. MKP-2 is constitutively expressed by neuronal cells and regulates 
neuronal diferentiation25. In our study, we observed the constitutive expression of MKP-2 in the murine spinal 
cord tissues, and furthermore its expression was signiicantly increased in EAE mice at the disease onset and peak 
stages compared with naïve mouse tissues, suggesting a potential role of MKP-2 in CNS compartment. Future 
experiments identifying MKP-2 expressing cells in both the CNS and immune systems would lead to better 
understanding of the speciic function of MKP-2 in diseases such as MS. While our further analysis underlines 
how MKP-2 modulates the peripheral immune responses, it is not known whether the molecule might also inlu-
ence EAE development and recovery through modulating CNS resident cells, e.g. myeloid microglia cells, and 
therefore CNS function such as neuron damage, repair, or demyelination/remyelination, and subsequently con-
tribute to disease clinical symptoms. Future studies determining the function of MKP-2 in the CNS will increase 
our understanding of its role in MS development.
In conclusion, our study reveals the important role of MKP-2 in EAE. MKP-2 deletion results in attenuated 
EAE severity, which is associated with reduced production of inlammatory cytokines by lymphocytes. And the 
potential mechanism of MKP-2 action in EAE is likely to be via antigen presenting DCs, as MKP-2 is required for 
the upregulation of MHC-II and costimulatory molecules during DC activation, and is essential in T cell activa-
tion and function. he data suggest that inhibition of MKP-2 expression or function may be a viable strategy in 
the treatment of CNS inlammatory diseases such as MS.

Ǥ Naïve C57BL/6 mice, and MKP-2+/+ and MKP-2−/− littermates on a C57BL/6 background were bred 
and maintained at the Biological Procedure Unit at the University of Strathclyde. MKP-2−/− mice were origi-
nally generated by Professor Plevin as previously described22. Female animals at 7–8 weeks of age were used in 
all experiments. All animal experiments were performed under the guidelines of the UK Animals (Scientiic 
Procedures) Act 1986 and were conducted under a Project License granted by the UK Home Oice and approved 
by the University of Strathclyde’s Animal Welfare and Ethical Review Body.
Ǥ Naïve C57BL/6 mice or MKP-2−/− and MKP-2+/+ littermates were 
immunized subcutaneously on day 0 with 100 µ l of 100 µ g MOG35–55 (ChinaPeptides Co Ltd) emulsiied in com-
plete freunds adjuvant (CFA; Sigma) supplemented with 3.65 mg Mycobacterium tuberculosis (BD Biosciences). 
In addition, each mouse received 100 ng pertussis toxin (PTX; Tocris Bioscience) in 100 µ l PBS injected intra-
peritoneally on day 0 and again on day 2. Mice were monitored daily for signs of disease development and given 
a clinical score based on the following evaluation system: 0 = no clinical sign; 0.5 = partial loss of tail tone; 
1.0 = complete loss of tail tone; 1.5 = altered gait; 2.0 = hind limb weakness; 2.5 = paralysis of one leg; 3.0 = hind 
limb paralysis; 3.5 = hind limb paralysis with significantly reduced mobility; 4.0 = forelimb involvement; 
5.0 = moribund.
Ǥ MKP-2+/+ and MKP-2−/− EAE mice were sacriiced at the planned 
dates. Following PBS perfusion, intact spinal cords were lushed out with PBS by hydrostatic pressure using a 
sterile 19G needle. Frozen spinal cord tissue sections were then stained with standard haematoxylin and eosin 
(H&E) staining or with anti-CD45, anti-CD4, anti-CD8, anti-CD11b and anti-CD11c antibodies (all purchased 
from eBioscience) followed by incubation with an appropriate biotin-conjugated secondary antibody (eBiosci-
ence, UK), horseradish peroxidise and ImmPACT AMEC red peroxidase substrate (Vector Lab, UK) for detection. 
Isotypes with matching IgG were used as negative controls for all antibody staining.
Ǥ Mice were sacriiced at various time points and spinal cord, spleen and inguinal draining 
lymph nodes (dLNs) were collected. RNA isolation was performed using TRIzol reagent (Life Technologies) 
as per manufacturer’s guidelines. Next, 2 µ g total RNA was reverse transcribed using the High Capacity cDNA 
Reverse Transcription Kit (Life Technologies UK). he cDNA obtained from reverse transcription was ana-
lysed for expression of various mRNA transcripts by quantitative PCR (qPCR) using the 2x Fast SYBR Green 
master mix (Life Technologies). MKP-2 and β -actin Primers were obtained from Sigma-Aldrich and designed 
using Primer3 sotware. List of primers used, (5′ –3′ ): MKP-2 forward TGCCAGAGAAGACTTGGTTT, MKP-2 
reverse TCCTCTTTCCTTTCCCTCTC; β -actin forward GTGGGCCGCTCTAGGCACCAA, β -actin reverse 
CTCTTTGATGTCACGCACGATTTC.
Ǥ Mice were sacriiced at various time points and spleen 
and dLNs were harvested for cell culture. Single cell suspensions from each mouse were cultured in 24-well plates 
at 4 × 106 cells/2 ml per well for spleen or 2 × 106 cells/2 ml per well for dLNs and stimulated with or without 
40 µ g/ml MOG35–55. For mRNA analysis, cells were collected at 10 mins, 30 mins, 1 hour, 2 hours and 4 hours ater 
MOG stimulation and MKP-2 mRNA levels were determined by qPCR. For cytokine analysis, supernatants from 
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the culture were collected ater 72 hours and the concentrations of IL-17, IFN-γ , IL-6, IL-22and CCL2 were deter-
mined by ELISA. All ELISA kits were purchased from eBioscience.
For polyclonal activation of CD4+ T cells, spleens from both MKP-2−/− and MKP-2+/+ mice were collected 
and cells were puriied from single cell suspensions using the CD4+ T cell isolation kit (Miltenyi Biotec) per man-
ufacturers guidelines. Following this, puriied CD4+ T cells (2 × 105) were added to 96-well plates which had been 
pre-coated overnight with 5 µ g/ml anti-CD3e (eBioscience). Soluble anti-CD28 (2 µ g/ml; eBioscience) was then 
added to each well and the cells incubated for 48 and 96 hours for cell proliferation MTT assay. Some plates were 
cultured for 72 hours and supernatants were collected for cytokine production test using ELISA.

Ǥ Bone marrow derived cells were generated from the 
culture of bone marrow from 6–7 week old MKP-2−/− and MKP-2+/+ mice. Both tibia and femurs were collected 
from mice and bone marrow lushed out and disaggregated to form a single cell suspension. For BMDCs, cells 
were re-suspended in growth medium composed of complete RPMI supplemented with GM-CSF. he BMDCs 
were harvested on day 7 and stimulated with or without 100 ng/ml LPS, 1 µ M CpG or 20 µ g/ml Poly(I:C) in 
12-well plates (2 × 106 cells/well), cells and supernatants were then harvested for various immunoassays. For bone 
marrow derived macrophages (BMMs), cells were cultured in complete DMEM growth medium supplemented 
with 30% L-cell (L929 cell culture derived). Ater 7 days of culture, BMMs were harvested and stimulated with or 
without 100 ng/ml LPS, 1 µ M CpG or 20 µ g/ml Poly(I:C) in 12-well plates (2 × 106 cells/well) for 24 hours and cells 
and supernatants harvested for immunoassays.
	Ǥ Individual cells from spleen and dLN tissues or BMDC/BMM culture were added to 
FACS tubes (0.5 × 106 cells per tube). To block non-speciic Fc receptors, cells were resuspended in α -mouse 
CD16/CD32 Fc block (eBioscience) for 10 minutes before incubation with the appropriate antibodies: anti-CD4, 
anti-CD8, anti-CD11c, anti-CD40, anti-CD80, anti-CD86, anti-MHC-II, anti-CD11b and anti-NOS2 (all 
from eBioscience). For intracellular NOS2 analysis, cells were ixed and permeabilized following cell surface 
staining using the intracellular ixation and permeabilization bufer set (eBioscience). Cells were then resus-
pended in 0.5 ml FACS bufer and analysed using a BD FACSCanto system and BD FACSDiva sotware (both BD 
Biosciences).
ǦǤ BMDCs were generated from MKP-2+/+ and MKP-2−/− mice. On day 7 cells 
were harvested and pulsed with or without 100 µ g/ml MOG peptide for 4 hours, cells were then washed with 
PBS thoroughly. Meanwhile spleen and dLNs tissues were collected from MKP-2+/+ mice at day 14 ater EAE 
immunisation, and CD4+ T cells were isolated by MACS cell separation kit (Miltenyi Biotec). Puriied CD4+ T 
cells were then cultured with MOG-pulsed or non-pulsed BMDCs at a ratio of 10:1 (Tc: DC). For analysis of T cell 
proliferation, cells were cultured in 96-well plates and an MTT assay was performed ater 96 hours co-culture. To 
analyse T cell cytokine production, 24 well plates were used for the co-culture and supernatants were collected 
ater 72 hours and IL-17 and IFN-γ concentrations determined by ELISA.
Ǥ Following euthanasia at the selected time points, blood samples from individual naïve 
and EAE mouse were harvested and serum collected. For nitric oxide (NO) production by BMMs, culture super-
natants were collected ater 24 hours LPS incubation. NO levels in the serum and BMMs supernatants were deter-
mined by measuring one of its stable oxidation products, nitrite (NO2−) by a standard Griess assay using the 
Griess reagent kit (Molecular Probes; Invitrogen).
Ǥ All data are shown as mean ± SEM. Statistical analysis of EAE clinical score data was performed 
using 2-way ANOVA with repeated measures and bonferroni post hoc tests. Other data presented in the study 
were analysed by two-tailed, unpaired student’s t test, one-way ANOVA or Mann-Whitney U test as appropriate. 
A P value of less than 0.05 was considered statistically signiicant.
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